Cargando…

Extrapulmonary Nontuberculous Mycobacterial Disease Surveillance — Oregon, 2014–2016

Nontuberculous mycobacteria (NTM), ubiquitous in soil and water, usually infect immunocompromised persons. However, even healthy persons are susceptible to infection through percutaneous inoculation. Although 77% of NTM diseases manifest as primarily pulmonary illnesses (1), NTM also infect skin, bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shih, David C., Cassidy, P. Maureen, Perkins, Kiran M., Crist, Matthew B., Cieslak, Paul R., Leman, Richard L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089334/
https://www.ncbi.nlm.nih.gov/pubmed/30091968
http://dx.doi.org/10.15585/mmwr.mm6731a3
_version_ 1783347006704451584
author Shih, David C.
Cassidy, P. Maureen
Perkins, Kiran M.
Crist, Matthew B.
Cieslak, Paul R.
Leman, Richard L.
author_facet Shih, David C.
Cassidy, P. Maureen
Perkins, Kiran M.
Crist, Matthew B.
Cieslak, Paul R.
Leman, Richard L.
author_sort Shih, David C.
collection PubMed
description Nontuberculous mycobacteria (NTM), ubiquitous in soil and water, usually infect immunocompromised persons. However, even healthy persons are susceptible to infection through percutaneous inoculation. Although 77% of NTM diseases manifest as primarily pulmonary illnesses (1), NTM also infect skin, bones, joints, the lymphatic system, and soft tissue. NTM infections can have incubation periods that exceed 5 years (2), often require prolonged treatment, and can lead to sepsis and death. Extrapulmonary NTM outbreaks have been reported in association with contaminated surgical gentian violet (3), nail salon pedicures (4), and tattoos received at tattoo parlors (5), although few surveillance data have been available for estimating the public health burden of NTM.* On January 1, 2014, the Oregon Health Authority designated extrapulmonary NTM disease a reportable condition. To characterize extrapulmonary NTM infection, estimate resources required for surveillance, and assess the usefulness of surveillance in outbreak detection and investigation, 2014–2016 extrapulmonary NTM surveillance data were reviewed, and interviews with stakeholders were conducted. During 2014–2016, 134 extrapulmonary NTM cases (11 per 1 million persons per year) were reported in Oregon. The age distribution was bimodal, with highest incidence among persons aged <10 years (20 per 1 million persons per year) and persons aged 60–69 years (18 per 1 million persons per year). The most frequently reported predisposing factors (occurring within 14–70 days of symptom onset) were soil exposure (41/98; 42%), immunocompromised condition (42/124; 34%), and surgery (32/120; 27%). Overall, 43 (33%) patients were hospitalized, 18 (15%) developed sepsis, and one (0.7%) died. Surveillance detected or helped to control two outbreaks at low cost. Jurisdictions interested in implementing extrapulmonary NTM surveillance can use the Council of State and Territorial Epidemiologists (CSTE) standardized case definition (6) for extrapulmonary NTM reporting or investigative guidelines maintained by the Oregon Health Authority (7).
format Online
Article
Text
id pubmed-6089334
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-60893342018-08-29 Extrapulmonary Nontuberculous Mycobacterial Disease Surveillance — Oregon, 2014–2016 Shih, David C. Cassidy, P. Maureen Perkins, Kiran M. Crist, Matthew B. Cieslak, Paul R. Leman, Richard L. MMWR Morb Mortal Wkly Rep Full Report Nontuberculous mycobacteria (NTM), ubiquitous in soil and water, usually infect immunocompromised persons. However, even healthy persons are susceptible to infection through percutaneous inoculation. Although 77% of NTM diseases manifest as primarily pulmonary illnesses (1), NTM also infect skin, bones, joints, the lymphatic system, and soft tissue. NTM infections can have incubation periods that exceed 5 years (2), often require prolonged treatment, and can lead to sepsis and death. Extrapulmonary NTM outbreaks have been reported in association with contaminated surgical gentian violet (3), nail salon pedicures (4), and tattoos received at tattoo parlors (5), although few surveillance data have been available for estimating the public health burden of NTM.* On January 1, 2014, the Oregon Health Authority designated extrapulmonary NTM disease a reportable condition. To characterize extrapulmonary NTM infection, estimate resources required for surveillance, and assess the usefulness of surveillance in outbreak detection and investigation, 2014–2016 extrapulmonary NTM surveillance data were reviewed, and interviews with stakeholders were conducted. During 2014–2016, 134 extrapulmonary NTM cases (11 per 1 million persons per year) were reported in Oregon. The age distribution was bimodal, with highest incidence among persons aged <10 years (20 per 1 million persons per year) and persons aged 60–69 years (18 per 1 million persons per year). The most frequently reported predisposing factors (occurring within 14–70 days of symptom onset) were soil exposure (41/98; 42%), immunocompromised condition (42/124; 34%), and surgery (32/120; 27%). Overall, 43 (33%) patients were hospitalized, 18 (15%) developed sepsis, and one (0.7%) died. Surveillance detected or helped to control two outbreaks at low cost. Jurisdictions interested in implementing extrapulmonary NTM surveillance can use the Council of State and Territorial Epidemiologists (CSTE) standardized case definition (6) for extrapulmonary NTM reporting or investigative guidelines maintained by the Oregon Health Authority (7). Centers for Disease Control and Prevention 2018-08-10 /pmc/articles/PMC6089334/ /pubmed/30091968 http://dx.doi.org/10.15585/mmwr.mm6731a3 Text en https://creativecommons.org/licenses/by/3.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Shih, David C.
Cassidy, P. Maureen
Perkins, Kiran M.
Crist, Matthew B.
Cieslak, Paul R.
Leman, Richard L.
Extrapulmonary Nontuberculous Mycobacterial Disease Surveillance — Oregon, 2014–2016
title Extrapulmonary Nontuberculous Mycobacterial Disease Surveillance — Oregon, 2014–2016
title_full Extrapulmonary Nontuberculous Mycobacterial Disease Surveillance — Oregon, 2014–2016
title_fullStr Extrapulmonary Nontuberculous Mycobacterial Disease Surveillance — Oregon, 2014–2016
title_full_unstemmed Extrapulmonary Nontuberculous Mycobacterial Disease Surveillance — Oregon, 2014–2016
title_short Extrapulmonary Nontuberculous Mycobacterial Disease Surveillance — Oregon, 2014–2016
title_sort extrapulmonary nontuberculous mycobacterial disease surveillance — oregon, 2014–2016
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089334/
https://www.ncbi.nlm.nih.gov/pubmed/30091968
http://dx.doi.org/10.15585/mmwr.mm6731a3
work_keys_str_mv AT shihdavidc extrapulmonarynontuberculousmycobacterialdiseasesurveillanceoregon20142016
AT cassidypmaureen extrapulmonarynontuberculousmycobacterialdiseasesurveillanceoregon20142016
AT perkinskiranm extrapulmonarynontuberculousmycobacterialdiseasesurveillanceoregon20142016
AT cristmatthewb extrapulmonarynontuberculousmycobacterialdiseasesurveillanceoregon20142016
AT cieslakpaulr extrapulmonarynontuberculousmycobacterialdiseasesurveillanceoregon20142016
AT lemanrichardl extrapulmonarynontuberculousmycobacterialdiseasesurveillanceoregon20142016